RT60 60mg*10vials

Retatrutide RT60 60mg*10vials

Retatrutide is a triple-receptor agonist peptide that simultaneously activates GLP-1, GIP, and glucagon receptors, representing an ultra-high-concentration metabolic research compound.

The 60mg single-vial specification offers an extremely high active ingredient load per vial, well-suited for ultra-long-term large animal studies, extreme high-dose validation experiments, and very large-scale multi-group parallel research projects. The high concentration minimizes the number of vials required for extended experiments, reducing operational errors and data variability from repeated dilution and solution changes.

Dual GLP-1 and GIP pathway activation supports advanced research into insulin sensitivity, glycemic regulation, and appetite-related signaling mechanisms. The glucagon receptor component adds energy expenditure and lipid metabolism pathways for comprehensive metabolic investigation.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Each batch undergoes rigorous purity testing, with a complete certificate of analysis provided.

10 vials per pack, designed for high-intensity preclinical research and large-scale laboratory operations.